Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
12/2003
12/18/2003US20030232802 Aryl and heteroaryl sulfonates
12/18/2003US20030232801 Identification of compounds for the treatment or prevention of proliferative diseases
12/18/2003US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases
12/18/2003DE10215316C1 Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer Quinoline and isoquinoline derivatives, to a pharmaceutical agent and their use as anti-inflammatory agents
12/18/2003CA2485164A1 Organic catalyst with enhanced solubility
12/17/2003EP1370558A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP0934276B1 Anthranilic acid derivatives as multi drug resistance modulators
12/17/2003EP0902781B1 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide
12/17/2003CN1462435A Optical data carrier containing phthalocyanine colouring agent as light absorbing compound in information layer
12/17/2003CN1462358A Optical data storage device containing Co-Phthalocyanin complex in optically writable information layer
12/17/2003CN1131215C Cyclic and heterocyclic n-substituted 'alpha'-iminoh-ydroxamic acid and carboxylic acids
12/17/2003CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/16/2003US6664293 For treatment and/or prevention of disorders in the central nervous system, particularly amnesia, dementia, Alzheimer's dementia
12/16/2003US6664269 Isoquinolinone derivatives
12/16/2003US6664250 Lactam derivatives as antiarrhythmic agents
12/11/2003WO2003101967A1 Preparation of chiral 1,2,3,4-tetrahydro-6,7-dialkoxy-3-isoquinolinecarboxylic acid and derivatives by reacting levodopa with formaldehyde or formaldehyde precursors
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2002100825A3 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
12/11/2003US20030229116 Enamine derivatives
12/11/2003US20030229113 Keratinocyte growth inhibitors and hydroxamic acid derivatives
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229077 Nitrogen-containing heterocyclic compounds
12/10/2003EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use
12/10/2003EP1368340A1 Piperazine derivatives as melanocortin receptor agonists
12/10/2003EP1368339A1 Substituted piperidines/piperazines as melanocortin receptor agonists
12/10/2003EP1368032A1 Excitatory amino acid receptor antagonists
12/10/2003CN1130199C Improved method of synthesis for 6,9-bis[(2-aminoethyl)amino] benzo[g] isoquinoline-5,10-dione and its dimaleate salt
12/04/2003WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/04/2003WO2003099818A1 Substituted quinazolinone compounds
12/04/2003WO2003099792A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
12/04/2003WO2003099786A2 Aromatic sulfones and their medical use
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225122 2-(S)-(6-(4-fluoro-benzyloxy)-3-oxo-3,4-dihydro-1H-isoquinolin -2-yl)- propionamide for example; Alzheimer's disease or senile dementia
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003CA2486966A1 Substituted quinazolinone compounds
12/04/2003CA2486962A1 Compounds
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003EP1367055A1 Isoquinolinyl carboxamides and their use as anticonvulsants
12/03/2003EP1366039A1 Piperazinylcarbonylquinolines and -isoquinolines
12/03/2003EP1366036A2 Compounds having activity as inhibitors of cytochrome p450rai
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
11/2003
11/27/2003WO2003097607A1 Tetrahydroisoquinoline derivatives
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030220498 Use of toxicologically benign iron salts or iron complexes as the catalysts, and commercially attractive aryl chlorides as well as various aryl sulfonates and aryl phosphonates can be used as starting materials
11/27/2003US20030220494 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220349 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists
11/27/2003US20030220325 Such as 1-(4-(phenylsulfonyl)-naphthyl)piperazine; for treating treating diseases related to 5-HT receptor; radiolabelling
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220318 New phenylalanine derivatives
11/27/2003US20030220298 Combrestatin a-1 phosphate and combrestatin b-1 phosphate prodrugs
11/27/2003CA2486764A1 Tetrahydroisoquinoline derivatives
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/26/2003EP1363907A2 Heterocycle carboxamides as antiviral agents
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363630A2 Kappa opioid receptor ligands
11/26/2003CN1458149A Use of phenolic dauricine in preparing myocardial ischemia medicine
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/20/2003WO2003095447A1 Process for the preparation of a hydrate of an anthranilic acid derivative
11/20/2003WO2003095428A1 Dopamine receptor modulators as antipsychotic agents
11/20/2003WO2003095426A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216409 Heteroaryl alkyl piperazine derivatives
11/20/2003US20030216396 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality, which are useful in the treatment of cancer, inflammation, osteoporosis and angiogenesis
11/20/2003CA2485130A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0927165B1 Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors
11/13/2003WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003WO2003092695A1 Bicyclo 4.4.0 antiviral derivatives
11/13/2003WO2003092688A2 Heterocyclic derivatives as opioid modulators
11/13/2003WO2003029221A8 Tetrahydroisochinolines, their production and the use thereof as analgesics
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002077609A3 Identification of compounds for the treatment or prevention of proliferative diseases
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003CA2753371A1 Heterocyclic derivatives as opioid receptor modulators
11/13/2003CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/12/2003EP1361216A1 Method of making a HIV-Protease inhibitor
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP0975599B1 Subtituted isoquinolines as ultra short acting neuromuscular blockers
11/12/2003EP0923636B1 Color-safe bleach boosters, compositions and laundry methods employing same
11/11/2003US6645979 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine
11/11/2003US6645939 Substituted β-alanine derivatives as cell adhesion inhibitors
11/06/2003WO2003091688A2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine n-oxides, and phosphine oxide-pyridine n-oxides, and devices made with such complexes
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 119